Preview

Archives of Pediatrics and Pediatric Surgery

Advanced search

Enteral formulas for nutritional support of patients with cystic fibrosis

https://doi.org/10.31146/2949-4664-apps-2-1-208-215

Abstract

Cystic fibrosis (CF) is a hereditary disease characterized by impaired functioning of the glands of external secretion, the phenomena of maldigestion, malabsorption, chronic inflammation in the bronchopulmonary system, which negatively affects the nutritional status. Among patients with CF, regardless of age, there is a high prevalence of malnutrition, which has a multifactorial nature and leads to somatic and psychological consequences, significantly worsens the course and prognosis of the disease, and reduces the quality of life. The high-risk group consists of adolescent children due to the increased energy needs of the body during this period and the progression of the severity of the disease with age. A good nutritional status (NS) is an important parameter for successful control of the CF flow. General dietary recommendations for CF include an increased energy value of food (up to 200% of the target values of kca /day for healthy individuals) while taking pancreatic enzymes. An increased intake of protein, fat, salt, and fat-soluble vitamins is recommended. Important nutritional factors are polyunsaturated fatty acids, fiber, pre-probiotics, trace elements, and antioxidants. It is necessary to take preventive measures to prevent the development of malnutrition and timely correct existing deficiencies, taking into account the individual characteristics of the patient. For this purpose, specialized therapeutic nutrition is used. A wide range of such products in the form of ready-made (drinks, yoghurts, creamy products) or dry mixes to increase the energy and biological value of the actual diet is the best option for correcting the nutritional needs of patients with CF. They have proven clinical efficacy and safety, are well absorbed and tolerated, convenient and easy to use for patients, which significantly increases compliance and improves the result of treatment. The available assortment allows you to choose a personalized approach to each patient, taking into account the general condition, age, existing complications, and associated diseases. The review highlights the causes of nutritional deficiency, changes in approaches to diet therapy against the background of targeted therapy, enteral nutrition products recommended for patients with MV in the territory of the Russian Federation and indications for their appointment.

About the Authors

T. Yu. Maksimycheva
Research Clinical Institute of Childhood of the Ministry of Health of the Moscow Region; Research Centre for Medical Genetics
Russian Federation


I. S. Krysanov
BIOTEKH University; A. I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation


D. V. Kurkin
A. I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation


E. V. Makarova
A. I. Yevdokimov Moscow State University of Medicine and Dentistry
Russian Federation


V. Yu. Ermakova
BIOTEKH University; Sechenov First Moscow State Medical University
Russian Federation


References

1. Kashirskaya N. Yu., Kapranov N. I. Kondratyeva E.I [CYSTIC FIDOSIS. 2nd edition].Moscow. Publishing House «MEDPRACTICA-M», 2021, 680 p. (in Russ.)@@ МУКОВИСЦИДОЗ. Издание 2-е., переработанное и дополненное (под редакцией Н. Ю. Каширской, Н. И. Капранова и Е. И. Кондратьевой). - М.: ИД «МЕДПРАКТИКА-М», 2021, 680 с. ISBN 978-5-98803-450-6

2. Kondratyeva E.I., Kashirskaya N. Yu., Kapranov N. I. [National consensus. Cystic fibrosis: definition, diagnostic criteria]. Moscow. Therapy. 2019. 356 p.(in Russ.)@@ Кондратьева Е. И., Каширская Н. Ю., Капранов Н. И. Национальный консенсус. Муковисцидоз: определение, диагностические критерии, терапия. М. 2019. 356 с.

3. [Cystic fibrosis (cystic fibrosis)] Clinical guidelines (age group - adults and children). 2021, KR372/1.@@ Клинические рекомендации «Кистозный фиброз (муковисцидоз)» (возрастная группа - взрослые и дети) 2021, КР372/1.

4. Turck D., Braegger C. P., Colombo C., Declercq D., Morton A., Pancheva R., Robberecht E., Stern M., Strandvik B., Wolfe S., Schneider S.M, Wilschanski M. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016 Jun;35(3):557-77. doi: 10.1016/j.clnu.2016.03.004.

5. Culhane S., George C., Pearo B., Spoede E. Malnutrition in cystic fibrosis: a review. Clin Pract 2013; 28:676-83. doi: 1177/088453361350786.

6. Maksimycheva T. Yu., Kondratyeva E. I., Sorvacheva T. N., Pyrieva E. A., Evdokimova T. A. Dietary intake of children with cystic fibrosis. Voprosy pitaniia [Problems of Nutrition]. 2020; 89 (1): 28-36. (in Russ.) doi: 10.24411/0042-8833-2020-10003.@@ Максимычева Т. Ю., Кондратьева Е. И., Сорвачева Т. Н., Пырьева Е. А., Евдокимова ТА. Состояние фактического питания детей, страдающих муковисцидозом. Вопр. питания. 2020: 89(1): 28-36. doi: 10.24411/0042-8833-2020-10003

7. Koletzko B., Ruhl-Bagheri I., Thiel I., Steinkamp G. Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients. Clinical Nutrition 1992;11(Suppl):39-40.

8. Steinkamp G., Demmelmair H., Ruhl-Bagheri I., Hardt H., Koletzko B. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. Journal of Pediatric Gastroenterology and Nutrition 2000;31:418-23.

9. Oudshoorn J.H., Klijn P. H., Hofman Z. et al. Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients. Journal of Cystic Fibrosis 2007;6(1):35-40.

10. Meshheryakov A.A., Pasechnik I. N., Kry`lov V. V. Respiratory and nutrition support: how to combine them? Kremlevskaya medicina. Klinicheskij vestnik. 2020; 3:138-143. (in Russ.) doi:10.26269/5hab-vv78.@@ Мещеряков, А. А., И. Н. Пасечник, В. В. Крылов Респираторная и нутритивная поддержки: как их совместить? Кремлевская медицина. Клинический вестник. 2020; 3:138-143. doi:10.26269/5hab-vv78

11. Powers S.W., Stark L. J., Chamberlin L. A., et al. Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial. JAMA Pediatr. 2015 May;169(5): e150636. doi: 10.1001/jamapediatrics.2015.0636

12. Doley J. Enteral Nutrition Overview. Nutrients. 2022 May 24;14(11):2180. doi: 10.3390/nu14112180.

13. Slae M., Wilschanski M. Prevention of malnutrition in cystic fibrosis. Curr Opin Pulm Med. 2019;25(6):674-9. 10.1097/MCP.0000000000000629.

14. Smyth R., Walters S. Oral calorie supplements for cystic fibrosis (review). Cochrane Database of Systematic Reviews. 2007(1): Art. No.: CD000406. doi: 10.1002/14651858.CD000406.pub2

15. Smyth R. L., Rayner O. Oral calorie supplements for cystic fibrosis. Cochrane Database Syst Rev. 2017 May 4;5(5): CD000406. doi: 10.1002/14651858.CD000406.pub5.

16. Francis D. K., Smith J., Saljuqi T., Watling R. M. Oral protein calorie supplementation for children with chronic disease. Cochrane Database of Systematic Reviews 2015, Issue 5. Art. No: CD001914. doi: 10.1002/14651858.CD001914.pub.

17. Sorvacheva T.N., Evdokimova T. A., Py`r`eva E.A., Volkova L. Yu. [Malnutrition in young children. principles of nutritional support]. Rossijskij pediatricheskij zhurnal. 2015; 18 (2): 47-53. (in Russ.)@@ Сорвачева Т. Н., Евдокимова Т. А., Пырьева Е. А., Волкова Л. Ю. Недостаточность питания у детей раннего возраста. Принципы нутритивной поддержки. Российский педиатрический журнал. 2015; 18 (2): 47-53

18. Kondratieva E. I., Maksimycheva T. Yu., Voronkova A. Yu., Sherman V. D. Experience of using specialized mixture of enteral nutrition in children with nutritive deficiency in cystic fibrosis. Medical alphabet. 2019;2(21):47-52. (In Russ.) doi: 10.33667/2078-5631-2019-2-21(396)-47-52.@@ Максимычева Т. Ю. Кондратьева Е. И., Воронкова А. Ю., Шерман В. Д. Опыт применения специализированной смеси энтерального питания у детей с нутритивным дефицитом при муковисцидозе. Медицинский алфавит. 2019; 2:21(396):47-53 doi: 10.33667/2078-5631-2019-2-21(396)-47-52.

19. Maksimycheva T. Y., Kondratyeva E. I., Odinaeva N. D. Experience of using semi-elemental formulas for enteral nutrition in children with cystic fibrosis. Meditsinskiy sovet = Medical Council. 2021;(1):228-234. (In Russ.) doi: 10.21518/2079-701X-2021-1-228-234/@@ Максимычева Т. Ю. Кондратьева Е. И., Одинаева Н. Д. Опыт использования полуэлементных продуктов для энтерального питания у детей с муковисцидозом. Медицинский совет.2021; (1): 206-212.

20. Maksimycheva T. Yu., Kondratyeva E.I, Odinaeva N. D. [The first experience of using a ready-to-use liquid form of a hypercaloric semi-element product for enteral nutrition in children with cystic fibrosis]. Questions of Practical Pediatrics. 2023;(1):55-61.(in Russ)@@ Максимычева Т. Ю., Кондратьева Е. И. Одинаева Н. Д. Первый опыт использования готовой к применению жидкой формы гиперкалорийного полуэлементного продукта для энтерального питания у детей с муковисцидозом. Вопросы практической педиатрии. 2023;(1):55-61.

21. Order of the Government of the Russian Federation of December 11, 2023 No. 3551-R. (in Russ.) (availably at: http://publication.pravo.gov.ru/document/0001202312110027 Accessed 20.10.2023)@@ Распоряжение Правительства РФ от 11 декабря 2023 г. № 3551-р. [http://publication.pravo.gov.ru/document/0001202312110027]

22. Bailey J., Krick S., Fontaine K. R. The Changing Landscape of Nutrition in Cystic Fibrosis: The Emergence of Overweight and Obesity. Nutrients. 2022 Mar 13;14(6):1216. doi: 10.3390/nu14061216.

23. Calella P., Valerio G., Brodlie M., Donini L. M., Siervo M. Cystic fibrosis, body composition, and health outcomes: a systematic review. Nutrition. 2018 Nov;55-56:131-139. doi: 10.1016/j.nut.2018.03.052.


Review

For citations:


Maksimycheva T.Yu., Krysanov I.S., Kurkin D.V., Makarova E.V., Ermakova V.Yu. Enteral formulas for nutritional support of patients with cystic fibrosis. Archives of Pediatrics and Pediatric Surgery. 2024;2(1):208-215. (In Russ.) https://doi.org/10.31146/2949-4664-apps-2-1-208-215

Views: 230


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2949-4664 (Print)